Positron, a molecular imaging solutions company focused on Nuclear Cardiology, has reported the sale of its Attrius PET scanner to Ochsner Health System of Louisiana.
Positron’s Attrius is a PET scanner optimized for myocardial perfusion imaging with several specialized features such as high quality PET imaging and cardiovascular specific interpretation tools.
Robert Bober, director of nuclear cardiology at Ochsner, said: “We are eager to offer Louisiana residents the best technology for coronary disease detection. Dr Bober went on to state, We selected Positron as our preferred vendor due to their dedication to high quality cardiology imaging and their vast amount of experience in this field.”
Joseph Oliverio, chief technology officer of Positron, said: “The Attrius sale to Ochsner demonstrates our expanding market beyond private cardiology practices. We are grateful to have such a prestigious hospital network join our user group. Positron has the ideal solution for thousands of cardiology groups and hospitals looking to improve their diagnostic accuracy at an affordable price.
“As a company we have always been at the forefront of cardiac PET and see the market for our products and industry continue to expand at a rapid rate. As evidence we are experiencing an unprecedented demand for our new device.”